This page shows the latest antimicrobial news and features for those working in and with pharma, biotech and healthcare.
The antibiotic Fetcroja, along with Zavicefta, will be made available as an option to help address antimicrobial resistance. ... continued ability to provide other healthcare – such as chemotherapy and surgical procedures – that might otherwise be
It is hoped that a fixed payment plan – independent of the amount of antibiotics used – will incentivise drug companies to increase their R&D efforts for antimicrobial treatments, in the race ... a recent BBC interview that only around 40 new
The prize will be awarded to a team of innovators who develop a point-of-care diagnostic test that will help combat antimicrobial-resistant infections. ... The test will help to support treatment decisions, reduce overuse of antibiotics and confront the
critical viral and bacterial infection, with the aim of delivering effective antimicrobial stewardship (AMS). ... are appropriate, to public health and vaccination programmes in helping to avoid reliance on antimicrobials.
issue of antimicrobial resistance.
The rapid identification of bloodstream infections and the detection of antimicrobial resistance genes are more essential than ever for hospitals and their patients,” he added.
More from news
Approximately 52 fully matching, plus 74 partially matching documents found.
However, we cannot be complacent when it comes to another rising infectious threat: antimicrobial resistance, or AMR.
in recent years, despite the ever- increasing health burden of antimicrobial resistance globally.
Antimicrobial resistance. There is a second pandemic that we have to deal with – the rising tide of antimicrobial resistance, where bacteria are becoming resistant to the antibiotics we routinely use to
Why antimicrobial resistance needs to be addressed with the same urgency as COVID-19. ... The World Health Organization (WHO) states that antimicrobial resistance (AMR) is a global concern.
In the forward of the 2019 CDC report on the threat posed by antimicrobial resistance he said simply: ‘We need stop referring to a coming post-antibiotic era – it’s already ... The plan is the latest step towards the government’s broader 20-year
More from intelligence
Approximately 8 fully matching, plus 15 partially matching documents found.
resistance, which is a part of the broader issue of antimicrobial resistance.
and to enable government to meet ambitious goals such as universal health coverage, global health security and continued innovation in areas of high unmet health needs such as antimicrobial resistance.
Destiny Pharma has appointed Neil Clark as CEO as the Brighton, UK-based firm plans a phase IIb trial for its lead antimicrobial candidate.
Ellison, who reprises her role as the secretary for public health that she has held since 2013, also has a wide remit that includes pharma as will have responsibility for: antimicrobial
drugs to help tackle the global crisis of antimicrobial resistance.”. ... Antimicrobial resistance is a huge area of unmet medical need and one of the greatest threats to human health.
More from appointments
Approximately 1 fully matching, plus 6 partially matching documents found.
For years, concerns have been mounting about a problem that has the potential to set our health services back 100 years: the rise of antimicrobial resistance. ... WHO. https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance. Published
Other recent progress includes NovaBiotics’ novel antimicrobial-immunomodulator, Nylexa, which is now set to enter phase 3 clinical trials in the UK for COVID-19 and non-COVID pneumonia (in hospitalised ... NP432, derived from NovaBiotics’
Up to 2 billion people, mainly in low- and middle-income countries, lack access to antimicrobials. ... Available at: https://www.healtheuropa.eu/antimicrobial-resistance/88272/. Accessed November 2019. World Health Organization. WHO global strategy for
Antimicrobial resistance is one of the greatest threats to human health, according to the World Health Organisation. ... Her illness is due to antimicrobial resistance (AMR) and it is not as rare as you might think.
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians navigating ... Antimicrobial resistance claims 5,
More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.
Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...